Search research articles
Contact Us
Filters
Showing results (191-200 of 196) with videos related to
Page
of 20
Sort By:
You have reached the last page of results.
This site can display upto 196 results.
Medrxiv : the Preprint Server for Health Sciences
|
July 9, 2024
Consortium Profile: The Methylation, Imaging and NeuroDevelopment (MIND) Consortium
Isabel K Schuurmans, Rosa H Mulder, Vilte Baltramonaityte, et al.
Translational Psychiatry
|
August 11, 2021
The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study
Diego Quattrone, Ulrich Reininghaus, Alex L Richards, et al.
Molecular Psychiatry
|
September 6, 2025
Consortium profile: the methylation, imaging and NeuroDevelopment (MIND) consortium
Isabel K Schuurmans, Rosa H Mulder, Vilte Baltramonaityte, et al.
Molecular Psychiatry
|
October 15, 2024
Methylomic signature of current cannabis use in two first-episode psychosis cohorts
Emma L Dempster, Chloe C Y Wong, Joe Burrage, et al.
Psychological Medicine
|
December 11, 2023
Cannabis use as a potential mediator between childhood adversity and first-episode psychosis: results from the EU-GEI case-control study
Giulia Trotta, Victoria Rodriguez, Diego Quattrone, et al.
Psychological Medicine
|
December 5, 2024
The impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorder in the EU-GEI case-control and UK Biobank studies
Isabelle Austin-Zimmerman, Edoardo Spinazzola, Diego Quattrone, et al.
Page
of 20
Search research articles
Search
Showing results (191-200 of 196) with videos related to
Sort By:
Page
of 20
You have reached the last page of results.
This site can display upto 196 results.
Medrxiv : the Preprint Server for Health Sciences
|
July 9, 2024
Consortium Profile: The Methylation, Imaging and NeuroDevelopment (MIND) Consortium
Isabel K Schuurmans, Rosa H Mulder, Vilte Baltramonaityte, et al.
Translational Psychiatry
|
August 11, 2021
The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study
Diego Quattrone, Ulrich Reininghaus, Alex L Richards, et al.
Molecular Psychiatry
|
September 6, 2025
Consortium profile: the methylation, imaging and NeuroDevelopment (MIND) consortium
Isabel K Schuurmans, Rosa H Mulder, Vilte Baltramonaityte, et al.
Molecular Psychiatry
|
October 15, 2024
Methylomic signature of current cannabis use in two first-episode psychosis cohorts
Emma L Dempster, Chloe C Y Wong, Joe Burrage, et al.
Psychological Medicine
|
December 11, 2023
Cannabis use as a potential mediator between childhood adversity and first-episode psychosis: results from the EU-GEI case-control study
Giulia Trotta, Victoria Rodriguez, Diego Quattrone, et al.
Psychological Medicine
|
December 5, 2024
The impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorder in the EU-GEI case-control and UK Biobank studies
Isabelle Austin-Zimmerman, Edoardo Spinazzola, Diego Quattrone, et al.
Page
of 20